Your browser doesn't support javascript.
loading
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.
Baragaña, Beatriz; Forte, Barbara; Choi, Ryan; Nakazawa Hewitt, Stephen; Bueren-Calabuig, Juan A; Pisco, João Pedro; Peet, Caroline; Dranow, David M; Robinson, David A; Jansen, Chimed; Norcross, Neil R; Vinayak, Sumiti; Anderson, Mark; Brooks, Carrie F; Cooper, Caitlin A; Damerow, Sebastian; Delves, Michael; Dowers, Karen; Duffy, James; Edwards, Thomas E; Hallyburton, Irene; Horst, Benjamin G; Hulverson, Matthew A; Ferguson, Liam; Jiménez-Díaz, María Belén; Jumani, Rajiv S; Lorimer, Donald D; Love, Melissa S; Maher, Steven; Matthews, Holly; McNamara, Case W; Miller, Peter; O'Neill, Sandra; Ojo, Kayode K; Osuna-Cabello, Maria; Pinto, Erika; Post, John; Riley, Jennifer; Rottmann, Matthias; Sanz, Laura M; Scullion, Paul; Sharma, Arvind; Shepherd, Sharon M; Shishikura, Yoko; Simeons, Frederick R C; Stebbins, Erin E; Stojanovski, Laste; Straschil, Ursula; Tamaki, Fabio K; Tamjar, Jevgenia.
Afiliación
  • Baragaña B; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Forte B; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Choi R; Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
  • Nakazawa Hewitt S; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Bueren-Calabuig JA; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Pisco JP; Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
  • Peet C; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Dranow DM; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Robinson DA; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Jansen C; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Norcross NR; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Vinayak S; Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
  • Anderson M; Beryllium Discovery Corp., Bainbridge Island, WA 98110.
  • Brooks CF; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Cooper CA; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Damerow S; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Delves M; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.
  • Dowers K; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Duffy J; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.
  • Edwards TE; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.
  • Hallyburton I; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Horst BG; Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.
  • Hulverson MA; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Ferguson L; Medicines for Malaria Venture, 1215 Geneva 15, Switzerland.
  • Jiménez-Díaz MB; Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
  • Jumani RS; Beryllium Discovery Corp., Bainbridge Island, WA 98110.
  • Lorimer DD; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Love MS; Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
  • Maher S; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Matthews H; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.
  • McNamara CW; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Miller P; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.
  • O'Neill S; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Ojo KK; The Art of Discovery, 48160 Derio, Bizkaia, Basque Country, Spain.
  • Osuna-Cabello M; Department of Medicine, University of Vermont, Burlington, VT 05405.
  • Pinto E; Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
  • Post J; Beryllium Discovery Corp., Bainbridge Island, WA 98110.
  • Riley J; Biology Department, Calibr at Scripps Research, La Jolla, CA 92037.
  • Rottmann M; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.
  • Sanz LM; Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.
  • Scullion P; Biology Department, Calibr at Scripps Research, La Jolla, CA 92037.
  • Sharma A; Department of Medicine, University of Vermont, Burlington, VT 05405.
  • Shepherd SM; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Shishikura Y; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Simeons FRC; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.
  • Stebbins EE; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Stojanovski L; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Straschil U; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Tamaki FK; Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.
  • Tamjar J; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland.
Proc Natl Acad Sci U S A ; 116(14): 7015-7020, 2019 04 02.
Article en En | MEDLINE | ID: mdl-30894487
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Cryptosporidium parvum / Criptosporidiosis / Inhibidores Enzimáticos / Lisina-ARNt Ligasa Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Cryptosporidium parvum / Criptosporidiosis / Inhibidores Enzimáticos / Lisina-ARNt Ligasa Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido